Systematic Safety Evaluation of Cold Plasma-Activated Liquid in Rabbits

Plasma-activated liquid (PAL) can effectively and selectively kill various types of cancer cells both in superficial and deeper tumors. As a promising novel approach to oncotherapy, the safety of PAL is essential in the clinic but has not been thoroughly assessed. In myeloma and blood tumors, the pa...

Full description

Bibliographic Details
Main Authors: Yujing Xu, Sansan Peng, Bing Li, Shuai Wang, Hao Zhang, Qiaosong Li, Zhijie Liu, Bo Guo, Dingxin Liu, Dehui Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Physics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphy.2021.659227/full
_version_ 1818738541549584384
author Yujing Xu
Sansan Peng
Bing Li
Shuai Wang
Hao Zhang
Qiaosong Li
Zhijie Liu
Bo Guo
Dingxin Liu
Dehui Xu
author_facet Yujing Xu
Sansan Peng
Bing Li
Shuai Wang
Hao Zhang
Qiaosong Li
Zhijie Liu
Bo Guo
Dingxin Liu
Dehui Xu
author_sort Yujing Xu
collection DOAJ
description Plasma-activated liquid (PAL) can effectively and selectively kill various types of cancer cells both in superficial and deeper tumors. As a promising novel approach to oncotherapy, the safety of PAL is essential in the clinic but has not been thoroughly assessed. In myeloma and blood tumors, the pathogenesis is in the bone marrow cavity. We have therefore evaluated the safety of PAL in New Zealand rabbits by intra-bone marrow injection, and provide a basis of further clinical research and application of PALs. In this study, both a plasma jet and plasma surface were used to treat saline solution, phosphate-buffered solution, and cell culture medium, to produce PAL. Then, oscillograms and optical emission spectra were evaluated to characterize the plasma discharge. Acute toxicity tests and safety evaluation studies were conducted by intra-bone marrow injection of PAL into New Zealand rabbits, while control rabbits received saline only. Body weight, vital organ coefficient, organ appearance, organ histopathology, blood cell and hemoglobin parameters, and blood biochemical indicators were tested on the 30th day after injection. We found that there was no mortality or loss of mobility throughout the experimental period. Acute toxicity tests showed that there were no PAL-related side effects in rabbits receiving the maximum dose of 700 μL PAL. PAL treatments did not affect body weight, organ coefficient, organ appearance, organ histopathology, or blood biochemical indicators. However, the percentage of lymphocytes decreased while the percentage of neutrophil granulocytes increased compared with the control group. In summary, our results indicate that PAL can be safely injected into bone marrow of New Zealand rabbits without significant toxicity.
first_indexed 2024-12-18T01:10:35Z
format Article
id doaj.art-b27839877332440e9cb0cf1469a2d694
institution Directory Open Access Journal
issn 2296-424X
language English
last_indexed 2024-12-18T01:10:35Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physics
spelling doaj.art-b27839877332440e9cb0cf1469a2d6942022-12-21T21:26:06ZengFrontiers Media S.A.Frontiers in Physics2296-424X2021-08-01910.3389/fphy.2021.659227659227Systematic Safety Evaluation of Cold Plasma-Activated Liquid in RabbitsYujing Xu0Sansan Peng1Bing Li2Shuai Wang3Hao Zhang4Qiaosong Li5Zhijie Liu6Bo Guo7Dingxin Liu8Dehui Xu9State Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi’an Jiaotong University, Xi’an, ChinaState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi’an Jiaotong University, Xi’an, ChinaThe School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, ChinaThe School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, ChinaState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi’an Jiaotong University, Xi’an, ChinaState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi’an Jiaotong University, Xi’an, ChinaState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi’an Jiaotong University, Xi’an, ChinaState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi’an Jiaotong University, Xi’an, ChinaState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi’an Jiaotong University, Xi’an, ChinaState Key Laboratory of Electrical Insulation and Power Equipment, Centre for Plasma Biomedicine, Xi’an Jiaotong University, Xi’an, ChinaPlasma-activated liquid (PAL) can effectively and selectively kill various types of cancer cells both in superficial and deeper tumors. As a promising novel approach to oncotherapy, the safety of PAL is essential in the clinic but has not been thoroughly assessed. In myeloma and blood tumors, the pathogenesis is in the bone marrow cavity. We have therefore evaluated the safety of PAL in New Zealand rabbits by intra-bone marrow injection, and provide a basis of further clinical research and application of PALs. In this study, both a plasma jet and plasma surface were used to treat saline solution, phosphate-buffered solution, and cell culture medium, to produce PAL. Then, oscillograms and optical emission spectra were evaluated to characterize the plasma discharge. Acute toxicity tests and safety evaluation studies were conducted by intra-bone marrow injection of PAL into New Zealand rabbits, while control rabbits received saline only. Body weight, vital organ coefficient, organ appearance, organ histopathology, blood cell and hemoglobin parameters, and blood biochemical indicators were tested on the 30th day after injection. We found that there was no mortality or loss of mobility throughout the experimental period. Acute toxicity tests showed that there were no PAL-related side effects in rabbits receiving the maximum dose of 700 μL PAL. PAL treatments did not affect body weight, organ coefficient, organ appearance, organ histopathology, or blood biochemical indicators. However, the percentage of lymphocytes decreased while the percentage of neutrophil granulocytes increased compared with the control group. In summary, our results indicate that PAL can be safely injected into bone marrow of New Zealand rabbits without significant toxicity.https://www.frontiersin.org/articles/10.3389/fphy.2021.659227/fullcold atmospheric plasmaplasma-activated liquidNew Zealand rabbitssafety evaluationtumor
spellingShingle Yujing Xu
Sansan Peng
Bing Li
Shuai Wang
Hao Zhang
Qiaosong Li
Zhijie Liu
Bo Guo
Dingxin Liu
Dehui Xu
Systematic Safety Evaluation of Cold Plasma-Activated Liquid in Rabbits
Frontiers in Physics
cold atmospheric plasma
plasma-activated liquid
New Zealand rabbits
safety evaluation
tumor
title Systematic Safety Evaluation of Cold Plasma-Activated Liquid in Rabbits
title_full Systematic Safety Evaluation of Cold Plasma-Activated Liquid in Rabbits
title_fullStr Systematic Safety Evaluation of Cold Plasma-Activated Liquid in Rabbits
title_full_unstemmed Systematic Safety Evaluation of Cold Plasma-Activated Liquid in Rabbits
title_short Systematic Safety Evaluation of Cold Plasma-Activated Liquid in Rabbits
title_sort systematic safety evaluation of cold plasma activated liquid in rabbits
topic cold atmospheric plasma
plasma-activated liquid
New Zealand rabbits
safety evaluation
tumor
url https://www.frontiersin.org/articles/10.3389/fphy.2021.659227/full
work_keys_str_mv AT yujingxu systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits
AT sansanpeng systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits
AT bingli systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits
AT shuaiwang systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits
AT haozhang systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits
AT qiaosongli systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits
AT zhijieliu systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits
AT boguo systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits
AT dingxinliu systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits
AT dehuixu systematicsafetyevaluationofcoldplasmaactivatedliquidinrabbits